The global cardiovascular drugs market is expected to reach $92.3 billion by 2026, according to a report from Acumen Research and Consulting.

Fresh data from the CDC’s National Center for Health Statistics suggests U.S. life expectancy is climbing for the first time since 2014—but heart disease remains the number-one threat to mortality in the country.

Berlin-based CV tech company Biotronik has hired cardiologist David Hayes, MD, as its first chief medical officer, the company announced Jan. 27.

Most cardiologists have been implicated in a malpractice lawsuit, according to Medscape’s annual Cardiologist Malpractice Report, and in many cases the litigation causes them to stop trusting their patients.

Well-to-do individuals shell out thousands—and sometimes tens of thousands—of dollars for “executive” screening programs at top-ranked hospitals. But is that money really well-spent?

Rich people live an average of seven to nine more disability-free years than their socioeconomically disadvantaged peers, according to research published in the Journals of Gerontology: Medical Sciences Jan. 15.

The American College of Cardiology on Jan. 13 announced a handful of changes to its executive staff, including promotions and structural changes within the ACC’s senior team.

A number of female cardiologists are leading, or preparing to lead, top cardiology organizations this year. Could 2020 mean a paradigm shift for the field?